Featured Post

Our CEO, Dr. Ana Montalban-Arques, spoke with Founded  about Adularia’s journey and our new approach in cancer therapy. The article...

We are excited to announce that Recolony is now Adularia . This change reflects an important shift in our company’s strategic direction...

We are beyond excited to share that Recolony has won the Top 100 Swiss Startups Public Voting 2024 in the Biotech category ! This award...

We’re Proud to Be Named One of the Top 100 Swiss Startups in 2024! Being included in this prestigious list is a testament to the hard...

The voting process will be opened until July 21 2024. You still have time to cast your vote using your LinkedIn account. You can vote for...

Recolony ranks 10th in this annual ranking created by 100 leading investors and industry experts of the Swiss Startup scene.

Recolony has been selected to be part of the Swiss National Startup Team 2022 and will join Venture Leaders Biotech next September in...